Andres Ozaita Mintegui,Arnau Busquets Garcia,Rafael Maldonado Lopez
申请号：
US14778266
公开号：
US09662320B2
申请日:
2013.03.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to antagonists of the cannabinoid receptor CBI for use in the treatment and prevention of diseases associated with neural dendritic abnormalities, such as Down's syndrome, Angelman's syndrome, Rett syndrome and tuberous sclerosis. More specifically, the invention provides a method of treatment or prevention of such diseases by the administration of the compound rimonabant.
